AllianceBernstein’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220M Sell
877,428
-185,274
-17% -$50.2M 0.07% 204
2025
Q4
$267M Sell
1,062,702
-39,099
-4% -$10.4M 0.08% 180
2025
Q3
$316M Sell
1,101,801
-26,523
-2% -$7.11M 0.1% 158
2025
Q2
$296M Sell
1,128,324
-143,266
-11% -$34.9M 0.1% 169
2025
Q1
$296M Buy
1,271,590
+250,486
+25% +$60.8M 0.11% 160
2024
Q4
$234M Buy
1,021,104
+380,624
+59% +$87.3M 0.08% 194
2024
Q3
$143M Buy
640,480
+172,479
+37% +$37.9M 0.05% 299
2024
Q2
$95.2M Buy
468,001
+55,877
+14% +$11.4M 0.03% 409
2024
Q1
$90M Sell
412,124
-919,825
-69% -$203M 0.03% 440
2023
Q4
$303M Buy
1,331,949
+29,607
+2% +$6.22M 0.12% 155
2023
Q3
$262M Buy
1,302,342
+493,633
+61% +$104M 0.11% 165
2023
Q2
$168M Buy
808,709
+152,850
+23% +$29.7M 0.07% 247
2023
Q1
$129M Sell
655,859
-21,598
-3% -$4.44M 0.06% 317
2022
Q4
$137M Sell
677,457
-18,085
-3% -$3.53M 0.06% 298
2022
Q3
$122M Buy
695,542
+14,196
+2% +$2.91M 0.06% 303
2022
Q2
$137M Buy
681,346
+31,640
+5% +$6.74M 0.06% 270
2022
Q1
$147M Sell
649,706
-1,082,517
-62% -$255M 0.06% 310
2021
Q4
$468M Buy
1,732,223
+178,030
+11% +$44.1M 0.17% 112
2021
Q3
$376M Sell
1,554,193
-68,041
-4% -$17.1M 0.15% 135
2021
Q2
$384M Buy
1,622,234
+139,915
+9% +$31.9M 0.15% 127
2021
Q1
$325M Buy
1,482,319
+458,111
+45% +$91.9M 0.14% 136
2020
Q4
$179M Buy
1,024,208
+51,551
+5% +$8.9M 0.08% 218
2020
Q3
$157M Buy
972,657
+56,652
+6% +$8.98M 0.08% 213
2020
Q2
$131M Buy
916,005
+161,279
+21% +$22.3M 0.08% 232
2020
Q1
$82M Buy
754,726
+574,646
+319% +$82.8M 0.06% 308
2019
Q4
$26.2M Sell
180,080
-9,489
-5% -$1.37M 0.01% 734
2019
Q3
$27.4M Sell
189,569
-36,162
-16% -$5.28M 0.02% 688
2019
Q2
$33.5M Sell
225,731
-10,101
-4% -$1.41M 0.02% 655
2019
Q1
$31M Buy
235,832
+29,442
+14% +$3.63M 0.02% 675
2018
Q4
$22.4M Sell
206,390
-56,404
-21% -$7.56M 0.02% 722
2018
Q3
$39.2M Buy
262,794
+61,134
+30% +$9.3M 0.03% 604
2018
Q2
$31.1M Buy
201,660
+5,234
+3% +$790K 0.02% 656
2018
Q1
$27.3M Sell
196,426
-6,059
-3% -$890K 0.02% 671
2017
Q4
$27.7M Sell
202,485
-4,096
-2% -$541K 0.02% 655
2017
Q3
$26.8M Sell
206,581
-10,534
-5% -$1.41M 0.02% 670
2017
Q2
$28.8M Buy
217,115
+277
+0.1% +$33.9K 0.02% 650
2017
Q1
$26.7M Buy
216,838
+1,674
+0.8% +$198K 0.02% 650
2016
Q4
$23.7M Sell
215,164
-8,710
-4% -$968K 0.02% 672
2016
Q3
$26.4M Buy
223,874
+9,704
+5% +$1.14M 0.02% 616
2016
Q2
$24M Buy
214,170
+2,561
+1% +$276K 0.02% 627
2016
Q1
$21.3M Buy
211,609
+832
+0.4% +$79.8K 0.02% 680
2015
Q4
$22.4M Buy
210,777
+109
+0.1% +$11.2K 0.02% 663
2015
Q3
$19.6M Sell
210,668
-1,107
-0.5% -$115K 0.02% 710
2015
Q2
$22.1M Sell
211,775
-6,434
-3% -$670K 0.02% 704
2015
Q1
$23.6M Buy
218,209
+26,883
+14% +$2.76M 0.02% 667
2014
Q4
$17.7M Sell
191,326
-3,681
-2% -$325K 0.01% 741
2014
Q3
$17M Sell
195,007
-475
-0.2% -$42.9K 0.01% 732
2014
Q2
$17.2M Buy
195,482
+7,275
+4% +$630K 0.01% 740
2014
Q1
$15.9M Buy
188,207
+195
+0.1% +$15.6K 0.01% 724
2013
Q4
$14.8M Sell
188,012
-12,963
-6% -$1.11M 0.01% 748
2013
Q3
$17.1M Sell
200,975
-4,570
-2% -$385K 0.02% 693
2013
Q2
$17.7M Buy
+205,545
New +$17.1M 0.02% 674

Other funds holding LH

AllianceBernstein's LH Position: Q1 2026 in Review

AllianceBernstein reduced its Labcorp (LH) stake by 17% in Q1 2026, selling an estimated $50.2M and leaving 877,428 shares worth $220M. The position accounts for 0.07% of the portfolio, ranked #204.

AllianceBernstein first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $468M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • AllianceBernstein held 877,428 shares of Labcorp worth $220M as of Q1 2026.
  • AllianceBernstein sold 185,274 Labcorp shares in Q1 2026, an estimated $50.2M.
  • Labcorp made up 0.07% of AllianceBernstein's portfolio in Q1 2026, its #204 holding.
  • AllianceBernstein first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Labcorp position peaked at $468M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.